PZLV - ETF AI Analysis
Top Page
Pzena U.S. Large Cap Value ETF (PZLV)
Rating:67Neutral
Price Target:―
Positive Factors
Value-Focused U.S. Large Caps
The fund targets large U.S. companies considered undervalued, which can appeal to investors seeking value-oriented exposure.
Broad Sector Diversification
Holdings are spread across several major sectors, including health care, financials, technology, and consumer-related industries, helping reduce reliance on any single area of the market.
Positive Year-to-Date Performance
The ETF has delivered a positive return so far this year, indicating that its value strategy has recently been rewarded by the market.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which can eat into long-term returns compared with lower-cost alternatives.
Concentration in Health Care and Financials
A large portion of the portfolio is in health care and financial stocks, increasing the impact that weakness in these sectors could have on the fund.
Several Weak Top Holdings
Many of the largest positions, including major health care and financial names, have shown weak year-to-date performance, which can drag on overall fund results.
PZLV vs. SPDR S&P 500 ETF (SPY)
AUM62.69M
RegionNorth America
Expense Ratio0.60%
Beta0.49
IssuerPzena
Inception DateApr 01, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume802
30 Day Avg. Volume20,610
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
31.91Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering39
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PZLV Summary
Pzena U.S. Large Cap Value ETF (PZLV) is an actively managed fund that focuses on large, established U.S. companies that appear cheap based on their earnings or assets. Instead of tracking an index, managers hand-pick value stocks across sectors like health care, financials, and technology. Well-known holdings include CVS Health and Wells Fargo. Someone might invest in this ETF to tilt their portfolio toward value stocks and seek long-term growth from solid companies that may be temporarily out of favor. However, the fund can go up and down with the stock market and may lag when growth or tech stocks are leading.
How much will it cost me?This ETF has an expense ratio of 0.60%, which means you’ll pay about $6 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, paying a professional team to research and pick value stocks rather than simply tracking an index.
What would affect this ETF?This ETF could benefit if the U.S. economy stays healthy, interest rates stabilize or fall, and investor sentiment shifts toward value stocks, which may help its large health care, financial, and technology holdings as well as companies like Baxter, Humana, and Wells Fargo. On the downside, higher interest rates, pressure on bank profits, changes to health care regulation, or a slowdown in consumer spending could hurt its financial and health care exposure and weigh on top holdings such as CVS, Capital One, and Dollar General.
PZLV Top 10 Holdings
PZLV is leaning heavily into U.S. health care and financials, with names like Humana and CVS helping to pull the fund higher as they keep grinding steadily upward. On the cyclical side, auto suppliers Lear and Magna have been quiet standouts, giving the portfolio a bit of industrial muscle. Tech exposure is more selective, with Skyworks adding some spark but not dominating the show. Offsetting these winners, Baxter has been losing steam and banks like Capital One and Wells Fargo have been lagging, creating a push‑and‑pull dynamic within this U.S.-focused value lineup.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Humana | 6.85% | $4.48M | $43.76B | 55.12% | 69 Neutral | |
| Baxter International | 4.65% | $3.04M | $10.49B | -35.24% | 45 Neutral | |
| CVS Health | 3.96% | $2.59M | $125.07B | 47.73% | 64 Neutral | |
| Skyworks Solutions | 3.68% | $2.40M | $10.57B | -2.39% | 70 Outperform | |
| Magna International | 3.66% | $2.39M | $17.45B | 66.68% | 77 Outperform | |
| Lear | 3.59% | $2.34M | $7.04B | 49.40% | 75 Outperform | |
| Dollar General | 3.51% | $2.29M | $24.26B | -1.68% | 73 Outperform | |
| Wells Fargo | 3.20% | $2.09M | $250.84B | 10.76% | 80 Outperform | |
| Metlife | 3.15% | $2.06M | $55.42B | 9.15% | 71 Outperform | |
| Fresenius Medical Care | 3.05% | $2.00M | $11.92B | -21.52% | 65 Neutral |
PZLV Technical Analysis
Positive
―
Price Trends
26.95
Positive
Market Momentum
0.48
Negative
75.25
Negative
84.26
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PZLV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.70, equal to the 50-day MA of 26.95, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.48 indicates Negative momentum. The RSI at 75.25 is Negative, neither overbought nor oversold. The STOCH value of 84.26 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PZLV.
PZLV Peer Comparison
Comparison Results
Performance Comparison
PZLV
Pzena U.S. Large Cap Value ETF
28.89
3.82
15.24%
FLCV
Federated Hermes MDT Large Cap Value ETF
―
―
―
ITAN
Sparkline Intangible Value ETF
―
―
―
DHLX
Diamond Hill Large Cap Concentrated ETF
―
―
―
MAVF
Matrix Advisors Value ETF
―
―
―
PRXV
Praxis Impact Large Cap Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents